We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01021943
Recruitment Status : Suspended
First Posted : December 1, 2009
Last Update Posted : July 24, 2014
Sponsor:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Primary Completion Date : No date given
  Study Completion Date : No date given